The impact of systemic disease-associated gingival enlargement on pediatric patients

Hessam Nowzari1, Sandra K Rich

  • 1Advanced Periodontics, University of Southern California, Los Angeles, California, USA.

Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)
|March 26, 2008
PubMed

Insights

Pediatric systemic diseases and medications can cause gingival enlargement, a widespread oral health issue. This article analyzes the risks and proposes treatment strategies for this drug-associated side effect in children.

Area of Science:

  • Pediatric systemic diseases and pharmacology.
  • Oral health and drug side effects.

Background:

  • Systemic diseases in children often require medication.
  • Drug side effects can significantly impact pediatric oral health.
  • Gingival enlargement is a notable adverse effect of certain pediatric medications.

Purpose of the Study:

  • To analyze the link between pediatric systemic diseases, prescribed medications, and gingival enlargement.
  • To highlight gingival overgrowth as a global pediatric health concern.
  • To propose a framework for managing drug-associated gingival enlargement in children.

Main Methods:

  • Analysis of current pediatric health trends.
  • Review of prescribed medications for pediatric physical and mental health conditions.
  • Assessment of drug-associated gingival enlargement in pediatric patients.

Main Results:

  • Gingival enlargement is a significant and widespread side effect in pediatric patients.
  • Drug-associated gingival overgrowth presents considerable morbidity and risks.
  • Current pediatric health trends indicate a global epidemic of gingival overgrowth.

Conclusions:

  • Drug-induced gingival enlargement is a serious issue in pediatric populations.
  • Effective management strategies are needed to address this adverse drug reaction.
  • A proactive framework is proposed for treating chronic disease side effects in children.